RA

Raziya Ahemadulla Quadri

Director Designated Partner DIN 07693267
DIN 07693267 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Raziya Ahemadulla Quadri

Data last updated:

Raziya Ahemadulla Quadri was a Designated Partner at Vitaziya Pharmaceuticals Llp (2017) and Director at At-Tibb Health Care Private Limited (from 2017). The companies operate in Pharma.

DIN 07693267
Primary Designation Designated Partner
Industry Pharma
First Appointment 19 Jan 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jan 20172017Active
At-Tibb Health Care Private Limited U51909MH2017PTC294909
Director16 May 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
At-Tibb Health Care Private Limited
Vitaziya Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Raziya Ahemadulla Quadri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raziya Ahemadulla Quadri

Raziya Ahemadulla Quadri was first appointed on 19 Jan 2017 as Designated Partner at Vitaziya Pharmaceuticals Llp.

Raziya Ahemadulla Quadri held 2 earlier board appointments: Vitaziya Pharmaceuticals Llp (Designated Partner, 19 Jan 2017 to 23 May 2017); At-Tibb Health Care Private Limited (Director, from 16 May 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available